Red X iconGreen tick iconYellow tick icon
Skip to main content

NZM, KStJ, GCLJ, Officer of Order Arts and Sciences (Cambodia), BSc(Hons) (VUW), BMedSc, MB ChB, MD (Otago), FRSNZ, FRCPA, FFSc (RCPA), FRCPath, FNZSP, HonFNZIMLS, AFNZIM (Anatomic Pathology)

Brett Delahunt is Professor of Pathology and Molecular Medicine at the Wellington School of Medicine and Health Sciences, University of Otago.  He is a Past President of the New Zealand Society of Pathologists (1996-2007), and has also served as President of the International Society of Urological Pathology (2007-2009), the Australasian Division of the International Academy of Pathology (2007-2009) and International Vice President of the International Academy of Pathology (2013-2014) He was a Board Member (2000 to 2013) of the Medical Laboratory Sciences Registration Board (later the Medical Sciences Council of New Zealand) being the inaugural Deputy Chair of the Council (2011 to 2013).

Professor Delahunt is currently Chair of the New Zealand Cancer Registry Board of Management. He is Editor of the international journal Pathology, and a member of several editorial boards of journals including The American Journal of Surgical Pathology, Modern Pathology, Histopathology and Human Pathology.  He is Chair of the National Scientific Advisory Committee of the Cancer Society of New Zealand (since 2001) and of the Scientific Advisory Committee of the Wellington Medical Research Foundation (since 1997).  He has been a Member of the WHO Renal Tumour Classification Panel since 1989 and in 2011 he was appointed a Member of the Union Internationale Contre la cancer (UICC) TNM Staging Expert Panel for Genitourinary Cancers.

Professor Delahunt has received numerous academic awards.  Among these he was awarded the Koss Medal of the International Society of Urological Pathology in 2003, the Gold Medal as a Distinguished Fellow of the Royal College of Pathologists of Australia in 2009, the Golden Jubilee Medal of the Wellington Medical Research Foundation in 2010 and The Distinguished Pathologist Medal of the International Academy of Pathology in 2013.  In 2004 he was admitted as an Officer of the New Zealand Order of Merit for services to pathology and in 2012 was elected a Fellow of the Royal Society of New Zealand.

His research interests involve all aspects of urologic pathology with emphasis on the diagnosis, classification, genetics and prognosis of prostatic and renal neoplasia. He was co-Chair of the ISUP Consensus Conference on the Handling and Staging of Radical Prostatectomy Specimens (2009), Chair of the ISUP Vancouver Consensus Conference on Renal Neoplasia (2012), Co-convener for the ISUP Prostate cancer Grading  Consensus conference (2014) and is Trial pathologist for the Trans-Tasman Radiation Oncology Prostate Cancer Trial.  Since 2011 he has been an International Member of the College of American Pathologists group to evaluate the critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer.  In 2013 he was appointed a member of the Ministry of Health Working Group for the Prostate Cancer Awareness and Quality Improvement Programme to coordinate the implementation of the recommendations of the Prostate Cancer Taskforce.

Publications

Marsland, M., Jiang, C. C., Faulkner, S., McEwan, K., Jobling, P., Oldmeadow, C., Delahunt, B., … Hondermarck, H. (2024). CCL2/CCR2 expression in locally advanced prostate cancer and patient long-term outcome: 10-year results from the TROG 03.04 RADAR trial. Cancers, 16, 2794. doi: 10.3390/cancers16162794 Journal - Research Article

Bullen, J., Nickel, B., McCaffery, K., Wilt, T. J., Smith, J., Boroumand, F., … Delahunt, B., … Bell, K. (2024). Impact of the diagnostic label for a low-risk prostate lesion: Protocol for two online factorial randomised experiments. BMJ Open, 14, e085947. doi: 10.1136/bmjopen-2024-085947 Journal - Research Other

Ray Das, S., Delahunt, B., Lasham, A., Li, K., Wright, D., Print, C., Slatter, T., Braithwaite, A., & Mehta, S. (2024). Combining TP53 mutation and isoform has the potential to improve clinical practice. Pathology. Advance online publication. doi: 10.1016/j.pathol.2024.02.003 Journal - Research Other

Warrick, J. I., Al-Ahmadie, H., Berman, D. M., Black, P. C., Flaig, T. W., Höglund, M., … Members of the ISUP Bladder Tumor Consensus Panel, including Delahunt, B. (2024). International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working group 4: Molecular subtypes of bladder cancer: Principles of classification and emerging clinical utility. American Journal of Surgical Pathology, 48, e32-e42. doi: 10.1097/PAS.0000000000002053 Journal - Research Article

Paner, G. P., Kamat, A., Netto, G. J., Samaratunga, H., Varma, M., Bubendorf, L., … Members of the ISUP Bladder Tumor Consensus Panel, including Delahunt, B. (2024). International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working group 2 grading of mixed grade, invasive urothelial carcinoma Including histologic subtypes and divergent differentiations, and non-urothelial carcinomas. American Journal of Surgical Pathology, 48(1), e11-e23. doi: 10.1097/PAS.0000000000002077 Journal - Research Article

Back to top